253 related articles for article (PubMed ID: 24867695)
1. Profiling and targeting of cellular bioenergetics: inhibition of pancreatic cancer cell proliferation.
Cheng G; Zielonka J; McAllister D; Tsai S; Dwinell MB; Kalyanaraman B
Br J Cancer; 2014 Jul; 111(1):85-93. PubMed ID: 24867695
[TBL] [Abstract][Full Text] [Related]
2. Bioenergetic properties of human sarcoma cells help define sensitivity to metabolic inhibitors.
Issaq SH; Teicher BA; Monks A
Cell Cycle; 2014; 13(7):1152-61. PubMed ID: 24553119
[TBL] [Abstract][Full Text] [Related]
3. GSK-3β Can Regulate the Sensitivity of MIA-PaCa-2 Pancreatic and MCF-7 Breast Cancer Cells to Chemotherapeutic Drugs, Targeted Therapeutics and Nutraceuticals.
Abrams SL; Akula SM; Meher AK; Steelman LS; Gizak A; Duda P; Rakus D; Martelli AM; Ratti S; Cocco L; Montalto G; Cervello M; Ruvolo P; Libra M; Falzone L; Candido S; McCubrey JA
Cells; 2021 Apr; 10(4):. PubMed ID: 33917370
[TBL] [Abstract][Full Text] [Related]
4. Antiproliferative effects of mitochondria-targeted cationic antioxidants and analogs: Role of mitochondrial bioenergetics and energy-sensing mechanism.
Cheng G; Zielonka J; McAllister D; Hardy M; Ouari O; Joseph J; Dwinell MB; Kalyanaraman B
Cancer Lett; 2015 Aug; 365(1):96-106. PubMed ID: 26004344
[TBL] [Abstract][Full Text] [Related]
5. Metabolic Mechanisms and a Rational Combinational Application of Carboxyamidotriazole in Fighting Pancreatic Cancer Progression after Chemotherapy.
Ju R; Fei K; Li S; Chen C; Zhu L; Li J; Zhang D; Guo L; Ye C
J Pharmacol Exp Ther; 2018 Oct; 367(1):20-27. PubMed ID: 30002095
[TBL] [Abstract][Full Text] [Related]
6. Combined inhibition of glycolysis and AMPK induces synergistic breast cancer cell killing.
Wu Y; Sarkissyan M; Mcghee E; Lee S; Vadgama JV
Breast Cancer Res Treat; 2015 Jun; 151(3):529-39. PubMed ID: 25975952
[TBL] [Abstract][Full Text] [Related]
7. Structural and functional remodeling of mitochondria as an adaptive response to energy deprivation.
Kuznetsov AV; Javadov S; Margreiter R; Grimm M; Hagenbuchner J; Ausserlechner MJ
Biochim Biophys Acta Bioenerg; 2021 Jun; 1862(6):148393. PubMed ID: 33549532
[TBL] [Abstract][Full Text] [Related]
8. Everolimus regulates the activity of gemcitabine-resistant pancreatic cancer cells by targeting the Warburg effect via PI3K/AKT/mTOR signaling.
Cui J; Guo Y; Wu H; Xiong J; Peng T
Mol Med; 2021 Apr; 27(1):38. PubMed ID: 33849427
[TBL] [Abstract][Full Text] [Related]
9. 2-Deoxy-d-glucose Promotes Buforin IIb-Induced Cytotoxicity in Prostate Cancer DU145 Cells and Xenograft Tumors.
Wanyan Y; Xu X; Liu K; Zhang H; Zhen J; Zhang R; Wen J; Liu P; Chen Y
Molecules; 2020 Dec; 25(23):. PubMed ID: 33297583
[TBL] [Abstract][Full Text] [Related]
10. 2-Deoxy-d-Glucose Can Complement Doxorubicin and Sorafenib to Suppress the Growth of Papillary Thyroid Carcinoma Cells.
Wang SY; Wei YH; Shieh DB; Lin LL; Cheng SP; Wang PW; Chuang JH
PLoS One; 2015; 10(7):e0130959. PubMed ID: 26134286
[TBL] [Abstract][Full Text] [Related]
11. Cyclooxygenase-2-dependent and -independent effects of celecoxib in pancreatic cancer cell lines.
El-Rayes BF; Ali S; Sarkar FH; Philip PA
Mol Cancer Ther; 2004 Nov; 3(11):1421-6. PubMed ID: 15542781
[TBL] [Abstract][Full Text] [Related]
12. [Enhancing effects of celecoxib on the growth inhibition of pancreatic carcinoma by gemcitabine treatment].
Xu G; Wu K; Wang XP; Zhao S
Zhonghua Yi Xue Za Zhi; 2005 Apr; 85(14):986-91. PubMed ID: 16060994
[TBL] [Abstract][Full Text] [Related]
13. Emodin reverses gemcitabine resistance in pancreatic cancer cells via the mitochondrial apoptosis pathway in vitro.
Liu DL; Bu H; Li H; Chen H; Guo HC; Wang ZH; Tong HF; Ni ZL; Liu HB; Lin SZ
Int J Oncol; 2012 Apr; 40(4):1049-57. PubMed ID: 22159556
[TBL] [Abstract][Full Text] [Related]
14. A review of the basics of mitochondrial bioenergetics, metabolism, and related signaling pathways in cancer cells: Therapeutic targeting of tumor mitochondria with lipophilic cationic compounds.
Kalyanaraman B; Cheng G; Hardy M; Ouari O; Lopez M; Joseph J; Zielonka J; Dwinell MB
Redox Biol; 2018 Apr; 14():316-327. PubMed ID: 29017115
[TBL] [Abstract][Full Text] [Related]
15. Regulation of pH by Carbonic Anhydrase 9 Mediates Survival of Pancreatic Cancer Cells With Activated KRAS in Response to Hypoxia.
McDonald PC; Chafe SC; Brown WS; Saberi S; Swayampakula M; Venkateswaran G; Nemirovsky O; Gillespie JA; Karasinska JM; Kalloger SE; Supuran CT; Schaeffer DF; Bashashati A; Shah SP; Topham JT; Yapp DT; Li J; Renouf DJ; Stanger BZ; Dedhar S
Gastroenterology; 2019 Sep; 157(3):823-837. PubMed ID: 31078621
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of autophagy and glycolysis by nitric oxide during hypoxia-reoxygenation impairs cellular bioenergetics and promotes cell death in primary neurons.
Benavides GA; Liang Q; Dodson M; Darley-Usmar V; Zhang J
Free Radic Biol Med; 2013 Dec; 65():1215-1228. PubMed ID: 24056030
[TBL] [Abstract][Full Text] [Related]
17. Comparison of HepaRG cells following growth in proliferative and differentiated culture conditions reveals distinct bioenergetic profiles.
Young CKJ; Young MJ
Cell Cycle; 2019 Feb; 18(4):476-499. PubMed ID: 30755072
[TBL] [Abstract][Full Text] [Related]
18. Mutant p53 prevents GAPDH nuclear translocation in pancreatic cancer cells favoring glycolysis and 2-deoxyglucose sensitivity.
Butera G; Pacchiana R; Mullappilly N; Margiotta M; Bruno S; Conti P; Riganti C; Donadelli M
Biochim Biophys Acta Mol Cell Res; 2018 Dec; 1865(12):1914-1923. PubMed ID: 30296496
[TBL] [Abstract][Full Text] [Related]
19. Glycolysis promotes the progression of pancreatic cancer and reduces cancer cell sensitivity to gemcitabine.
Dai S; Peng Y; Zhu Y; Xu D; Zhu F; Xu W; Chen Q; Zhu X; Liu T; Hou C; Wu J; Miao Y
Biomed Pharmacother; 2020 Jan; 121():109521. PubMed ID: 31689601
[TBL] [Abstract][Full Text] [Related]
20. Combined targeting of histone deacetylases and hedgehog signaling enhances cytoxicity in pancreatic cancer.
Chun SG; Zhou W; Yee NS
Cancer Biol Ther; 2009 Jul; 8(14):1328-39. PubMed ID: 19421011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
